Clinical trials: Secondary Prevention
Superficial Venous Thrombosis of Leg, Secondary Prevention
Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
The objective of the study is to demonstrate the superiority of the mesoglycan (Prisma®), compared to placebo, in reducing the incidence of thromboembolic complications (relapse / extension of superficial venous thrombosis (SVT)…
- Trial name
- NCT03428711
- Testing
- Mesoglycan Oral Tablet
- Where
- Italy
- Volunteers
- 560 people
- Sponsor
- Quovadis Associazione
Cerebral Hemorrhage, Intracranial Hemorrhages
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
The study evaluates the effects of antithrombotic drugs (anticoagulant drugs or antiplatelet drugs) for prevention of ischaemic events in patients With recent intracerebral haemorrhage.
- Conditions
- Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation, Anticoagulant-Induced Bleeding
- Trial name
- STATICH (NCT03186729)
- Testing
- Antithrombotic Agent
- Where
- 3 sites in Denmark, Norway and 1 more
- Volunteers
- 134 people
- Sponsor
- Oslo University Hospital
Acute Coronary Syndrome, Nutrition
Secondary PRevention in Cardiovascular Disease by a Nursing Guided Program (SPRING)
DESIGN: Controlled clinical trial with single randomization, unmasked, open and multicentric. CENTERS: University Hospital of A Coruña and University Hospital of Ferrol CONDITION TO STUDY: Acute Coronary Syndrome (ACS).
- Conditions
- Acute Coronary Syndrome, Nutrition, Physical Activity, Secondary Prevention
- Trial name
- SPRING (NCT03234023)
- Testing
- INTERVENTION GROUP
- Where
- 2 sites in Spain
- Volunteers
- 484 people
- Sponsor
- University Hospital A Coruña
Suicide, Suicide, Attempted
Suicide Prevention Among Recipients of Care
Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics.
- Conditions
- Suicide, Suicide, Attempted, Suicidal Ideation, Social Support
- Trial name
- SPARC (NCT04893447)
- Testing
- SPI+, SP+CC (Caring Contacts)
- Where
- United States
- Volunteers
- 1,520 people
- Sponsor
- St. Luke's Health System, Boise, Idaho
Cardiac Rehabilitation, Secondary Prevention
Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot)
The goal of this clinical pilot / feasibility study is to determine the feasibility of conducting a large-scale clinical effectiveness trial of the aktivplan digital intervention in cardiac rehabilitation patients.
- Conditions
- Cardiac Rehabilitation, Secondary Prevention, Cardiovascular Diseases
- Trial name
- NCT06025526
- Testing
- aktivplan, Usual care
- Where
- 2 sites in Austria
- Volunteers
- 34 people
- Sponsor
- Ludwig Boltzmann Institute for Digital Health and Prevention
Cardiovascular Diseases, Chronic Disease
Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.
The goal of this open label randomized controlled trial is to evaluate the efficacy of an intervention through health education based on the Chronic Care Model's implementation to increase therapeutic adherence in patients with…
- Conditions
- Cardiovascular Diseases, Chronic Disease, Secondary Prevention, Coronary Disease
- Trial name
- AT-PSC (NCT06510946)
- Testing
- (Health education program) To increase therapeutic adherence in patients with secondary prevention for cardiovascular disease
- Where
- Spain
- Volunteers
- 90 people
- Sponsor
- Universidad Miguel Hernandez de Elche
Ischemic Stroke, Intracranial Arteriosclerosis
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
The goal of this clinical trial is to learn about efficacy and safety of dual antiplatelet therapy in ischemic stroke with intracranial artery stenosis.
- Conditions
- Ischemic Stroke, Intracranial Arteriosclerosis, Secondary Prevention, Antiplatelet Drug
- Trial name
- PATH-ICAS (NCT06243133)
- Testing
- clopidogrel for 90 days combined with aspirin for 90 days, clopidogrel for 30 days combined with aspirin for 90 days
- Where
- China
- Volunteers
- 1,100 people
- Sponsor
- Sichuan Provincial People's Hospital
Myocardial Infarction, Secondary Prevention
Improving Cardiac Secondary Prevention
The purpose of this study is to determine whether providing individuals with personalized information on cellular aging, including telomere length, will stimulate them to adhere to cardiac prevention strategies and improve…
- Trial name
- NCT03269708
- Testing
- Education regarding telomere length
- Where
- Canada
- Volunteers
- 200 people
- Sponsor
- Western University, Canada
Primary Prevention of Sudden Cardiac Arrest, Secondary Prevention of Sudden Cardiac Arrest
S-ICD® System Post Approval Study
The purpose of the S-ICD Post Approval Study is to document long term safety and effectiveness outcomes associated with the implantation of the SQ-RX pulse generator and Q-TRAK electrode in a commercial clinical setting.
- Trial name
- NCT01736618
- Testing
- S-ICD System
- Where
- 87 sites in United States
- Volunteers
- 1,766 people
- Sponsor
- Boston Scientific Corporation
Secondary Prevention, Cardiovascular Disease With Mention of Arteriosclerosis
Mexican Registry of Dyslipidemia in Patients at High Risk and Very High Risk of Atherosclerotic Cardiovascular
Background. Atherosclerotic cardiovascular disease (ACVD) comprising coronary disease, cerebrovascular disease, peripheral artery disease, and aortic atherosclerosis caused 8.9 million deaths worldwide according to reports…
- Conditions
- Secondary Prevention, Cardiovascular Disease With Mention of Arteriosclerosis, Dyslipidemias
- Trial name
- REMEXDIS (NCT05542719)
- Testing
- application
- Where
- Mexico
- Volunteers
- 13,166 people
- Sponsor
- Coordinación de Investigación en Salud, Mexico
Urinary Tract Infections in Children, Secondary Prevention
Preventing Urinary Tract Infections With E. Coli Nissle:
Urinary tract infections (UTIs) account for 5-14% of pediatric emergency department visits annually. At the moment, up to one third of children suffering of acute (UTI) will have a new infection and there is a lack of effective…
- Trial name
- FinNissle (NCT04608851)
- Testing
- E. coli Nissle
- Where
- 5 sites in Finland
- Volunteers
- 530 people
- Sponsor
- University of Oulu
Mobile Applications, Secondary Prevention
The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Stroke
The aim of the present study was to quantitatively assess the risk factors that may affect the re-occurrence of a CVD event and the use of a commercially available mobile application Samsung Health for the assessment of…
- Conditions
- Mobile Applications, Secondary Prevention, Stroke
- Trial name
- NCT04821518
- Where
- Poland
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- Poznan University of Medical Sciences
Primary Prevention of Sudden Cardiac Arrest, Secondary Prevention of Sudden Cardiac Arrest
Longitudinal Surveillance Study of the 4-SITE Lead/Header System
Post-approval studies of implanted leads provide an opportunity to observe and assess patient outcomes and technology performance in a real-world setting.
- Trial name
- LSS of 4-SITE (NCT01596595)
- Where
- 111 sites in United States, Australia and 1 more
- Volunteers
- 1,820 people
- Sponsor
- Boston Scientific Corporation
Cardiovascular Diseases, Secondary Prevention
ICF in Secondary Prevention of Cardiovascular Disease
The aim of this study was to develop a practical protocol based on the ICF(The International Classification of Functioning, Disability, and Health) the risk factors of cardiovascular disease (CVD) in secondary prevention.
- Conditions
- Cardiovascular Diseases, Secondary Prevention, Risk Factor, Cardiovascular
- Trial name
- NCT04590287
- Where
- Poland
- Volunteers
- 120 people
- Sponsor
- Poznan University of Medical Sciences
Venous Thromboembolism, Secondary Prevention
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
This open-label, single arm prospective cohort study will assess the safety of dabigatran etexilate in secondary prevention of venous thromboembolism in paediatric patients.
- Trial name
- NCT02197416
- Testing
- dabigatran etexilate
- Where
- 62 sites in United States, Austria and 20 more
- Volunteers
- 214 people
- Sponsor
- Boehringer Ingelheim
Socioeconomic Status, Secondary Prevention
Socioeconomic Status, Secondary Prevention Activities and Recurrence After a Myocardial Infarction
This is a nationwide cohort study on real-world patients (n≈30,000) surviving a first myocardial infarction (MI) 2006-2013 and alive to attend a routine 1-year follow-up.
- Conditions
- Socioeconomic Status, Secondary Prevention, Myocardial Infarction, Cardiovascular Disease
- Trial name
- NCT04199663
- Volunteers
- 30,191 people
- Sponsor
- Karolinska Institutet
Stroke, Secondary Stroke Prevention
The SUCCEED Trial of Secondary Stroke Prevention
The purpose of this study is to test a newly-developed outpatient clinic and community-based care intervention called SUCCEED (Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End…
- Trial name
- SUCCEED (NCT01763203)
- Testing
- Care Management+Community Health Worker, Usual Care
- Where
- 6 sites in United States
- Volunteers
- 487 people
- Sponsor
- University of California, Los Angeles
Acute Coronary Syndrome, Cardiac Rehabilitation
Outpatient Cardiac Tele-Rehabilitation in a Public Sports Center
The aim of this study is to establish an innovative Cardiac Tele-Rehabilitation (CTR) model. It could expands assistance resources through coordination with public administrations, developing a physical exercise program (PEP)…
- Conditions
- Acute Coronary Syndrome, Cardiac Rehabilitation, Telerehabilitation, Secondary Prevention
- Trial name
- NCT04121702
- Testing
- Cardiac Rehabilitation
- Where
- Spain
- Volunteers
- 90 people
- Sponsor
- Juan Izquierdo García
Secondary Prevention
Improving Adherence Healthy Lifestyle With a Smartphone Application Based After Surgery in Cancer Patients
Background: The cancer-related lymphedema (BCRL) is the abnormal accumulation of fluid in the lymphatic system and can develop immediately after surgery / radiotherapy of breast cancer, or may appear months later.
- Trial name
- APPCOMCAN (NCT01915043)
- Testing
- health education for lymphedema prevention
- Where
- Spain
- Volunteers
- 65 people
- Sponsor
- University of Malaga
Stroke, Secondary Prevention
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
This trial will enroll approximately 6,000 patients with recent embolic stroke of unknown source (ESUS). Patients will be randomized to dabigatran or acetylsalicyclic acid (ASA) (1:1 ratio) and have visits every three months.
- Trial name
- NCT02239120
- Testing
- optional ASA as comedication, ASA 100 mg
- Where
- 569 sites in United States, Argentina and 40 more
- Volunteers
- 5,390 people
- Sponsor
- Boehringer Ingelheim